Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Donepezil

Donepezil

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Donepezil

49 trials tracked of Donepezil: 22 in phase 3 or 4 and 2 with published results. The most-cited published study has 15 citations.

49Trials tracked
22Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 18 Phase 3 4 Phase 2 14 Phase 1 11 Other / NA 2
  1. Phase 4 Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease Completed · 15 cited
  2. Phase 4 Monitoring Anti-Dementia Drugs by Serum Levels Completed
  3. Phase 4 Neural Correlates In Mild Alzheimer's Disease Completed
  4. Phase 4 Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease Completed
  5. Phase 4 The Impact of Arousal Threshold in Obstructive Sleep Apnea Completed
  6. Phase 4 Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults Completed
Show 43 more trials
  1. Phase 4 Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil Completed
  2. Phase 4 Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke Completed
  3. Phase 4 Detecting an Early Response to Donepezil With Measures of Visual Attention Completed
  4. Phase 4 The Effect of Donepezil on Gait and Balance in Parkinson's Disease Completed
  5. Phase 4 The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease Completed
  6. Phase 4 Corticolimbic Degeneration and Treatment of Dementia Completed
  7. Phase 4 Antidepressant Medication Plus Donepezil for Treating Late-life Depression Completed
  8. Phase 4 Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease Completed
  9. Phase 4 Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly Completed
  10. Phase 4 A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease Completed
  11. Phase 4 The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility Completed
  12. Phase 4 Combination Treatment Study for Memory Impairment and Depression Completed
  13. Phase 3 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed
  14. Phase 3 Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease Completed
  15. Phase 3 Efficacy and Safety Study of Shenwu Capsule Completed
  16. Phase 3 Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment Completed
  17. Phase 2 SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Completed
  18. Phase 2 Effect of Donepezil on Smoking Completed
  19. Phase 2 Donepezil HCl & Cognitive Deficits in Autism Completed
  20. Phase 2 Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) Completed
  21. Phase 2 Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease Completed
  22. Phase 2 The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism Completed
  23. Phase 2 Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period Completed
  24. Phase 2 Mayo Acute Stroke Trial for Enhancing Recovery Completed
  25. Phase 2 Randomized Controlled Study of Donepezil in Fragile X Syndrome Completed
  26. Phase 2 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome Completed
  27. Phase 2 Effects of Cholinergic Augmentation on Measures of Balance and Gait Completed
  28. Phase 2 BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. Completed
  29. Phase 2 Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction Completed
  30. Phase 2 A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type Completed
  31. Phase 1 A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other Completed
  32. Phase 1 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions Completed
  33. Phase 1 A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants Completed
  34. Phase 1 Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects Completed
  35. Phase 1 MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005) Completed
  36. Phase 1 Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) Completed
  37. Phase 1 Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) Completed
  38. Phase 1 Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults Completed
  39. Phase 1 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions. Completed
  40. Phase 1 Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain Completed
  41. Phase 1 Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease Completed
  42. N/A Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture Completed
  43. N/A Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease Completed

Showing the 49 most-cited and recently-updated of 49 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.